SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-496959
Filing Date
2016-03-08
Accepted
2016-03-08 17:21:02
Documents
3
Period of Report
2016-03-07
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d158970d8k.htm 8-K 17729
2 EX-99.1 d158970dex991.htm EX-99.1 8065
3 GRAPHIC g158970g95d21.gif GRAPHIC 2741
  Complete submission text file 0001193125-16-496959.txt   30902
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 161492473
SIC: 2834 Pharmaceutical Preparations